Table 2. Summary of the performed studies.
Hb: Hemoglobin; MCV: Mean corpuscular volume; MCH: Mean corpuscular hemoglobin; MCHC: Mean corpuscular hemoglobin concentration; WBC: White blood cell count; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase; GGT: Gamma-glutamyl transferase; LDH: Lactate dehydrogenase; INR: International normalized ratio; FBG: Fasting blood glucose; HbA1c: Glycated hemoglobin; LDL-C: Low-density lipoprotein cholesterol; HDL: High-density lipoprotein cholesterol; HAV: Hepatitis A virus; HBsAg: Hepatitis B surface antigen; HCV: Hepatitis C virus; ANA: Antinuclear antibody; ASMA: Anti-smooth muscle antibody; TIBC: Total iron binding capacity
| Investigations | ||
| Test | Result | Normal values |
| Hb | 14.6 g/dl | 13.5-17.5 g/dL |
| MCV | 82.2 fL | 80-100 fL |
| MCH | 27.4 pg | 27-33 pg |
| MCHC | 33.4 g/dL | 32-36 g/dL |
| Reticulocytes | 1.2% | 0.5%-1.5% |
| WBC | 7500 cells/μL | 4,500-11,000 cells/μL |
| Platelets | 178,000 cells/μL | 150,000-450,000/μL |
| Total bilirubin | 1.02 mg/dL | 0.3-1.2 mg/dL |
| Unconjugated bilirubin | 1.00 mg/dL | 0.2-1.0 mg/dL |
| Total proteins | 8.08 g/dL | 6.0-8.3 g/dL |
| Albumin | 4.94 g/dL | 3.4-5.4 g/dL |
| ALT | 120 U/L | 10-40 U/L |
| AST | 100 U/L | 10-34 U/L |
| ALP | 58.28 U/L | 40-129 U/L |
| GGT | 30 U/L | 9-48 U/L |
| LDH | 180 U/L | 140-280 U/L |
| INR | 1.2 | <1.3 |
| FBG | 150 mg/dL | <100 mg/dL |
| HbA1c | 8.00 | <5.7% |
| Total cholesterol | 220 | <200 mg/dL |
| LDL-C | 190 | <100 mg |
| HDL | 35 | 40-50 mg |
| HAV | Non-reactive | |
| Blood urea | 20 mg/dL | |
| Serum creatinine | 1 mg/dL | |
| HBsAg | Non-reactive | |
| HCV | Non-reactive | |
| ANA | Negative | |
| ASMA | Negative | |
| Serum iron | 210 mcg/dL | 60-170 mcg/dL |
| Serum ferritin | 640 ng/mL | 25-350 ng/mL |
| TIBC | 430 mcg/dL | 250-450 mcg/dL |
| Transferrin saturation | 48.84% | 20-50% |
| Genetic testing | No abnormal genes | |
| Liver ultrasound | Fatty liver | |
| Fibroscan | Grade 2 fibrosis (F2) | |